The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel

Inherited predisposition occurs in 5–10% of all prostate cancer (CaP) patients, but the genes involved in conferring genetic susceptibility remain largely unknown. Several lines of evidence indicate that germline mutations in BRCA1 and BRCA2 might be associated with an increased risk for CaP. Three...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Vazina, A, Baniel, J, Yaacobi, Y, Shtriker, A, Engelstein, D, Leibovitz, I, Zehavi, M, Sidi, A A, Ramon, Y, Tischler, T, Livne, P M, Friedman, E
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2000
Sujets:
Regular Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2374645/
https://ncbi.nlm.nih.gov/pubmed/10945492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1249
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires